中国药物滥用防治杂志2024,Vol.30Issue(4) :634-636.DOI:10.15900/j.cnki.zylf1995.2024.04.012

注射用哌拉西林钠他唑巴坦钠致粒细胞缺乏2例分析

Analysis of 2 Cases of Agranulocytosis Induced by Piperacillin Sodium and Tazobactam Sodium for Injection

江君微 蔡杰 陶苗苗
中国药物滥用防治杂志2024,Vol.30Issue(4) :634-636.DOI:10.15900/j.cnki.zylf1995.2024.04.012

注射用哌拉西林钠他唑巴坦钠致粒细胞缺乏2例分析

Analysis of 2 Cases of Agranulocytosis Induced by Piperacillin Sodium and Tazobactam Sodium for Injection

江君微 1蔡杰 1陶苗苗2
扫码查看

作者信息

  • 1. 浙江省温岭市中医院药剂科,浙江 温岭 317500
  • 2. 浙江省温岭市中医院中医内科,浙江 温岭 317500
  • 折叠

摘要

回顾性分析我院使用注射用哌拉西林钠他唑巴坦钠引起粒细胞缺乏病例2 例,结合文献,探索其发生粒细胞缺乏的机制、症状及处置措施,提醒医护人员在使用注射用哌拉西林钠他唑巴坦钠过程中应高度重视其血液系统的不良反应,加强用药监测.

Abstract

Two cases of agranulocytosis caused by piperacillin sodium and tazobactam sodium for injection in our hospital were retrospectively analyzed.Combined with the literature,the mechanism,symptoms and treatment measures of agranulocytosis were explored.It was reminded that medical staff should attach great importance to the adverse reactions of the blood system during the use of piperacillin sodium and tazobactam sodium for injection,and strengthen the monitoring of drug use.

关键词

注射用哌拉西林钠他唑巴坦钠/粒细胞缺乏/不良反应

Key words

Piperacillin sodium and tazobactam sodium for injection/Agranulocytosis/Adverse reaction

引用本文复制引用

基金项目

温岭市科技局项目(2022S00088)

出版年

2024
中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
参考文献量6
段落导航相关论文